Abstract
Treatments that modify the biochemical composition of the brain or otherwise affect neurotransmission can, as a consequence, alter one or more of the brain’s three output channels: behavior; hormone secretion from neuroendocrine organs; and processes controlled by autonomic nerves (e.g., cardiac rhythm). Caffeine administration affects the levels and turnover rates of catecholamines (Berkowitz and Spector 1971; Schlosberg et al. 1981) and serotonin (Fernstrom and Fernstrom, this volume p. 107) in the CNS and may also interrupt adenosine-mediated neurotransmission. Moreover, caffeine’s brain effects are known to lead to the cardiovascular and behavioral changes that are summarized in this volume by Robertson and Curatolo (p. 77) and Dews (p. 86) respectively. This chapter considers the evidence that caffeine consumption can affect the brain’s third output channel, neuroendocrine secretion, in experimental animals and in human subjects.
Some of these studies were supported in part by grants from the International Life Sciences Institute
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aldridge A, Parsons WD, Neims AH (1977) Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene. Life Sci 21: 967–974
Arnaud MJ (1976 a) Identification, kinetic and quantitative study of [12–14C] and [1-Me-14C]caffeine metabolites in rat’s urine by chromatographic separations. Biochem Med 16: 67–76
Arnaud MJ (1976b) Metabolism of 1,3,7-trimethyldihydrouric acid in the rat: new metabolic pathways of caffeine. Experientia 32: 1238–1240
Arnold MA, Carr DB, Togasaki DM, Pian MC, Martin JB (1982) Caffeine stimulates β-endorphin release in blood but not in cerebrospinal fluid. Life Sci 32: 1017–1024
Avogaro P, Capri C, Pais M, Cazzolato G (1973) Plasma and urine Cortisol behavior and fat mobilization in man after coffee ingestion. Isr J Med Sci 9: 114–119
Bellet S, Roman L, DeCastro O, Evin Kim K, Kershbaum A (1969 a) Effect of coffee ingestion on catecholamine release. Metabolism 18: 288–291
Bellet S, Kostis J. Roman L, DeCastro O (1969 b) Effect of coffee ingestion on adrenocortical secretion in young men and dogs. Metabolism 18: 1007–1012
Berkowitz BA, Spector S (1971) Effect of caffeine and theophylline on peripheral catecholamines. Eur J Pharmacol 13: 193–196
Clemens JA, Fuller RW (1979) Differences in the effects of amphetamine and methylphenidate on brain dopamine turnover and serum prolactin concentration in reserpine-treated rats. Life Sci 24: 2077–2082
Cohen MR, Nurnberger JI, Pickar D, Gershon E, Bunney WE (1981) Dextroamphetamine infusions in normals result in correlated increases of plasma β-endorphin and Cortisol immunoreactivity. Life Sci 29: 1243–1247
Colton T, Gosselin RE, Smith RP (1968) The tolerance of coffee drinkers to caffeine. Clin Pharmacol Ther 9: 31–39
Cornish HH, Christman AA (1957) A study of the metabolism of theobromine, theophylline and caffeine in man. J Biol Chem 228: 315–323
Costa C, Trovato A, DePasquale A (1977) Effects of caffeine on corticosterone production in rats. Communication at Joint Meeting of German and Italian Pharmacologists, Venice
Daubresse JC, Luyckx A, Demey-Ponsart E, Fracnhimont P, Lefebvre P (1973) Effects of coffee and caffeine on carbohydrate metabolism, free fatty acid, insulin, growth hormone and Cortisol plasma levels in man. Acta Diabetol Lat 10: 1069–1084
DePasquale A, Costa G, Trovato A, Ceserani R (1979) Effect of prostaglandins on the increased corticosterone output induced by caffeine in the rat. Prostaglandins Med 3: 97–103
Dunwiddie TV, Worth T (1982) Sedative and anti-convulsant effects of adenosine in mouse and rat. J Pharmacol Exp Ther 220: 70–76
Eddy NB, Downs AW (1928) Tolerance and cross-tolerance in the human subject to the diuretic effect of caffeine, theophylline and theobromine. J Pharmacol Exp Ther 33: 167–174
Ensinck JW, Stoll RW, Gale CC, Santen RJ, Touber JL, Williams RH (1970) Effect of aminophyl-line on the secretion of insulin, glucagon, luteinizing hormone and growth hormone in humans. J Clin Endocrinol Metab 31: 153–161
Geffner ME, Lippe BM, Kaplan SA, Itami RM (1982) The use of theophylline as an in vivo probe of adrenocortical function. J Clin Endocrinol Metab 55: 56–60
Goldstein A, Kaizer S, Whitby O (1969) Psychotropic effects of caffeine in man. IV. Quantitative and qualitative difference associated with habituation to coffee. Clin Pharmacol Ther 10: 489–497
Jung RT, Shetty PS, James WPT, Barrand MA, Callingham BA (1981) Caffeine: its effects on catecholamines and metabolism in lean and obese humans. Clin Sci 60: 527–535
Knych ET, Eisenberg RM (1979) Effects of amphetamine on plasma corticosterone in the conscious rat. Neuroendocrinology 29: 110–118
Kraicer J, Ducommun P, Jobin M, Rervp C, van Rees GP, Fortier C (1963) Pituitary and plasma TSH response to stress in the intact and adrenalectomized rat. Fed Proc 22: 507
Latini R (1981) Urinary excretion of an uracilic metabolite from caffeine by rat, monkey and man. Toxicol Lett 7: 267–272
Levi L (1967) The effect of coffee on the function of the sympathoadrenomedullary system in man. Acta Med Scand 181: 431–438
Londos C, Wolff J (1977) Two distinct adenosine-sensitive sites on adenylate cyclase. Proc Natl Acad Sci USA 74: 5482–5486
Maitre M, Ciesielski L, Lehmann A, Kempf E, Mandel P (1975) Protective effect of adenosine and nicotinamide against audiogenic seizure. Biochem Pharmacol 23: 2807–2816
Martin JB, Reichlin S, Brown GM (1977) Clinical neuroendocrinology. Davis, Philadelphia, pp 201–228
Moskowitz MA, Rubin D, Liebschutz J, Munro HN, Mowak TS, Wurtman RJ (1977) The permissive role of hypothermia in the disaggregation of brain polysomes by L-dopa or D-amphetamine. J Neurochem 28: 779–782
Mueller GP, Twohy CP, Chen JT, Advis JP, Meites J (1976) Effects of L-tryptophan and restraint stress on hypothalamic and brain serotonin turnover, and pituitary TSH and prolactin release in rats. Life Sci 18: 715–724
Oberman Z, Hershberg M, Jaskolka A, Havell A, Hoerer E, Laurian L (1975) Changes in plasma Cortisol, glucose, free fatty acids after caffeine ingestion in obese women. Isr J Med Sci 11: 33–36
Ravitz AJ, Moore KE (1977) Effects of amphetamine, methylphenidate and cocaine on serum prolactin concentrations in the male rat. Life Sci 21: 267–272
Rice, RW, Critchlow V (1976) Extrahypothalamic control of stress-induced inhibition of GH secretion in the rat. Endocrinology 99: 970–976
Robertson D, Frolich JC, Carr RK, Watson JT, Hollifield JW, Shand DG, Oates JA (1978) Effects of caffeine on plasma renin activity, catecholamines and blood pressure. N Engl J Med 298: 181–186
Robertson D, Wade D, Workman R, Woosley RL, Oates JA (1981) Tolerance to the humoral and hemodynamic effects of caffeine in man. J Clin Invest 67: 1111–1117
Schlosberg AJ, Fernstrom JD, Kopczynski MC, Cusack BM, Gillis MA (1981) Acute effects of caffeine injections on neutral amino acids and brain monoamine levels in rats. Life Sci 29: 173–183
Snyder SH, Katims JJ, Annau Z, Bruns RF, Daly JW (1981) Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci USA 78: 3260–3264
Spindel ER, Mueller GP, Wurtman RJ (1978) D-Amphetamine: effects of TRH immunoreactivity in regions of rat brain and on plasma TSH (Abstr 398). Program of the 60th Annual Meeting of the Endocrine Society
Spindel ER, Arnold MA, Cusack B, Wurtman RJ (1980) Effects of caffeine on anterior pituitary and thyroid function in the rat. J Pharmacol Exp Ther 214: 58–62
Spindel ER, Griffith L, Wurtman RJ (1983) Neuroendocrine effects of caffeine. II. Effects on thyrotropin and corticosterone secretion. J Pharmacol Exp Ther 225: 346–350
Spindel ER, McCall A, Carr D, Arnold MA, Griffith L, Wurtman RJ (to be published) Neuroendocrine effects of caffeine. III. Anterior pituitary effects limited to stimulation of adrenal axis
Sullivan FM, McElhatton PR, Elmazar MM (1978) Studies on the teratogenicity of caffeine. Proceedings of First Annual Caffeine Committee Workshop, International Life Sciences Institute, Honolulu
Tang-Liu DD, Williams RL, Reigelman S (1983) Disposition of caffeine and its metabolites in man. J Pharmacol Exp Ther 224: 180–185
Terry LC, Willoughby JO, Brazeau P, Martin JB, Patel Y (1976) Antiserum to somatostatin prevents stress-induced inhibition of growth hormone secretion in the rat. Science 192: 565–567
van Calker D, Muller M, Hamprecht B (1979) Adenosine regulates, via two different types of receptors, the accumulation of cAMP in cultures brain cells. J Neurochem 33: 999–1005
Yehuda S, Wurtman RJ (1972) The effects of D-amphetamine and related drugs on colonic temperatures of rats kept at various ambient temperatures. Life Sci 11: 851–859
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Spindel, E.R., Wurtman, R.J. (1984). Neuroendocrine Effects of Caffeine in Rat and Man. In: Dews, P.B. (eds) Caffeine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69823-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-69823-1_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69825-5
Online ISBN: 978-3-642-69823-1
eBook Packages: Springer Book Archive